Month: January 2025

Ocugen, Inc. Announces First Patient Dosed in Phase 1 Clinical Trial of OCU200—a Novel Integrin-Targeting Biologic for Diabetic Macular Edema

MALVERN, Pa., Jan. 16, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused...

Avacta Announces Positive New Data from the AVA6000 Phase 1 trial Demonstrating Clinically Meaningful Tumor Shrinkage in Patients with Salivary Gland Cancers

Meaningful tumor shrinkage observed in five out of 10 patients with partial and minor responses and 90% disease control rate...

Sibannac, Inc. and Celebrity Television Personality William Henry Announce First Podcast Interview for Starwalker Cafe and Plant Medicine Travel Destinations

Scottsdale, Arizona--(Newsfile Corp. - January 16, 2025) - Sibannac, Inc. (OTC Pink: SNNC), a Nevada corporation (the "Company"), announced the...

Transmission Electron Microscope Market to grow by USD 528.8 Million (2024-2028), driven by focus on nanotechnology, with a report on how AI is reshaping the landscape – Technavio

NEW YORK, Jan. 16, 2025 /PRNewswire/ -- Report with market evolution powered by AI - The global transmission electron microscope market...

Universal Technical Institute, Inc. to Hold Fiscal First Quarter 2025 Conference Call on Wednesday, February 5, 2025, at 4:30 p.m. ET

PHOENIX, Jan. 15, 2025 /PRNewswire/ -- Universal Technical Institute, Inc. (NYSE: UTI) (the "Company"), a leading workforce solutions provider of transportation,...

OnPoint AR-AI Receives Award for Granted U.S. Patent Covering Augmented Reality (AR) Display for Spinal Rod Placement Related Applications

OnPoint Surgical, a medical technology company pioneering Augmented Reality (AR) guidance and artificial intelligence (AI) for neurosurgical and orthopedic spinal...

error: Content is protected !!